Medifast, Inc. Announces Second Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/31/2026
- Take-Two stock drops as GTA 6 leaks continue
- GameStop posts higher income despite revenue drop in Q2 2026
- At least eight die, 18 missing after ferry capsizes off North Cyprus
- PG&E downgraded by Wells Fargo, BMO as California wildfire reform falls short
- Goldman Sachs raises humanoid robot forecast, sees auto role
Medifast (MED) PT Raised to $249 at DA Davidson
August 3, 2018 8:52 AM EDTDA Davidson raised its price target on Medifast (NYSE: MED) to $249.00 (from $201.00) while maintaining a Buy rating.
Analyst Linda Bolton Weiser commented, "MED exceeded consensus for 2Q18 sales and EPS--sales were +55% to $117M, exceeding consensus of $102M by 15%, and accelerating from 40% growth in 1Q18. EPS... More
Medifast (MED) Tops Q2 EPS by 16c; Raises Outlook
August 2, 2018 4:24 PM EDTMedifast (NYSE: MED) reported Q2 EPS of $1.16, $0.16 better than the analyst estimate of $1.00. Revenue for the quarter came in at $117.3 million versus the consensus estimate of $103.78 million.
GUIDANCE:
Medifast sees Q3 2018 EPS of $1.05-$1.10, versus the consensus of $0.96. Medifast sees Q3... More
